Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis

被引：10
作者：
El Rassy, Elie [1 ]
Assi, Tarek [1 ]
El Karak, Fadi [1 ]
Ghosn, Marwan [1 ]
Kattan, Joseph [1 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Fac Med, Dept Oncol, Beirut, Lebanon
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2017年 / 41卷 / 02期
关键词：
CANCER;
D O I：
10.1016/j.clinre.2016.11.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E26 / E28
页数：3
相关论文
共 10 条
[1]   Gemcitabine Plus Nab-paclitaxel as Second-line and Beyond Treatment for Metastatic Pancreatic Cancer: A Single Institution Retrospective Analysis [J].
Bertocchi, Paola ;
Abeni, Chiara ;
Meriggi, Fausto ;
Rota, Luigina ;
Rizzi, Anna ;
Di Biasi, Brunella ;
Aroldi, Francesca ;
Ogliosi, Chiara ;
Savelli, Giordano ;
Rosso, Edoardo ;
Zaniboni, Alberto .
REVIEWS ON RECENT CLINICAL TRIALS, 2015, 10 (02) :142-145
[2]  
Burris HA, 1997, J CLIN ONCOL
[3]   Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literature [J].
Caparello, Chiara ;
Vivaldi, Caterina ;
Fornaro, Lorenzo ;
Musettini, Gianna ;
Pasquini, Giulia ;
Catanese, Silvia ;
Masi, Gianluca ;
Lencioni, Monica ;
Falcone, Alfredo ;
Vasile, Enrico .
FUTURE ONCOLOGY, 2016, 12 (07) :901-908
[4]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825
[5]   Pancreatic cancer: from state-of-the-art treatments to promising novel therapies [J].
Garrido-Laguna, Ignacio ;
Hidalgo, Manuel .
NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (06) :319-334
[6]   Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort [J].
Portal, Alix ;
Pernot, Simon ;
Tougeron, David ;
Arbaud, Claire ;
Bidault, Anne Thirot ;
de la Fouchardiere, Christelle ;
Hammel, Pascal ;
Lecomte, Thierry ;
Dreanic, Johann ;
Coriat, Romain ;
Bachet, Jean-Baptiste ;
Dubreuil, Olivier ;
Marthey, Lysiane ;
Dahan, Laetitia ;
Tchoundjeu, Belinda ;
Locher, Christophe ;
Lepere, Celine ;
Bonnetain, Franck ;
Taieb, Julien .
BRITISH JOURNAL OF CANCER, 2015, 113 (07) :989-995
[7]  
Salem ME, 2014, ASCO ANN M P S, V32
[8]  
Vogl U, 2016, ANN ONCOL, V27, P52
[9]   Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial [J].
Von Hoff, Daniel D. ;
Ramanathan, Ramesh K. ;
Borad, Mitesh J. ;
Laheru, Daniel A. ;
Smith, Lon S. ;
Wood, Tina E. ;
Korn, Ronald L. ;
Desai, Neil ;
Trieu, Vuong ;
Iglesias, Jose L. ;
Zhang, Hui ;
Soon-Shiong, Patrick ;
Shi, Tao ;
Rajeshkumar, N. V. ;
Maitra, Anirban ;
Hidalgo, Manuel .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) :4548-4554
[10]   Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: Single institution retrospective review of efficacy and toxicity [J].
Zhang Y. ;
Hochster H. ;
Stein S. ;
Lacy J. .
Experimental Hematology & Oncology, 4 (1)
1